Introduction
The insulin-like growth factor-I receptor (IGF-IR) is a multifunctional membrane-associated tyrosine kinase that is mitogenic (Baserga, 1994; Reiss et al., 1998b) , protects normal and tumor cells from apoptosis (Gluckman et al., 1992; Sell et al., 1995) , and plays an important role in supporting cellular transformation by different viral and cellular oncoproteins, including T-antigens (Baserga, 1995; Baserga et al., 1997; Del Valle et al., 2002b) . In the CNS, IGF-IR and its corresponding ligands, IGF-I and IGF-II, are elevated during embryonic and early postnatal development of the brain, however, their expression decrease significantly during adolescence and adult life (Glick et al., 1993; LeRoith et al., 1993) . In the cerebellar cortex, IGF-IR is found in cells of the granular layer, where IGF-I is mitogenic and protects cerebellar neurons from low potassium-induced apoptosis (D'Mello et al., 1993; Cui et al., 1998) . Tumors of the nervous system secrete both IGF-I and IGF-II and often overexpress IGF-IR (Glick et al., 1993) . In medulloblastomas, the presence of IGF-I-binding sites were first reported by Kurihara et al. (1989) . Later, IGF-IR protein and IGF-I mRNA were detected in human medulloblastoma cell lines (Patti et al., 2000) , and overexpression of IGF-II was found in medulloblastomas and rhabdomyosarcomas, which develop in mice with deletions of the PTCH gene (Hahn et al., 2000) . In addition, sonic hedgehog (shh) and IGF-II were found to cooperate in the transformation of nestin expressing neuronal progenitors leading to the development of cerebellar tumors in an experimental mouse model (Rao et al., 2004) . Importantly, a strong immunolabeling with the antibody against phosphorylated form of the IGF-IR (pY1316 IGF-IR) has been demonstrated in multiple medulloblastoma clinical samples (Lassak et al., 2002; Del Valle et al., 2002a) , further supporting possible involvement of this tyrosine kinase receptor in the development/progression of this cerebellar neoplasm.
Multiple reports have demonstrated strong antitumoral potential of experimental strategies targeting the IGF-IR. These include anti-IGF-I and anti-IGF-IR neutralizing antibodies Araki et al., 2006) , dominant negative mutants (Reiss et al., 1998a , antisense strategies (Resnicoff et al., 1996; Andrews et al., 2001) , and RNA interference (Liao and Wang, 2005) . Although these multiple anti-IGF-IR factors inhibit cell proliferation, compromise cell survival in vitro and attenuate tumor growth in experimental animals, clinical testing with the involvement of these anti-IGF-IR strategies are either not very successful, or have not been initiated, mostly because of inefficient drug delivery systems. Therefore, demands for the development of highly specific, easily deliverable small molecules against the IGF-IR are increasing. NVP-AEW541 is a pyrrolo [2,3-d] pyrimidine derivative -a small molecular weight kinase inhibitor of the IGF-IR, which specifically abrogates IGF-I-mediated IGF-IR autophosphorylation, and the IGF-IR downstream signaling pathways (Garcia-Echeverria et al., 2004; Scotlandi et al., 2005) . The antitumor potential of the NVP-AEW541 has been recently shown in animal models for myelomas, and lymphomas, as well as some solid tumors including prostate cancer (Scotlandi et al., 2005) .
Here, we demonstrate that NVP-AEW541 can efficiently attenuate the growth and survival of mouse (BsB8) and human (D384) medulloblastoma cell lines. In monolayer cultures, the effects of NVP-AEW541 are mostly associated with G1 arrest. However, the treatment was much more effective in anchorage-independent culture conditions, where both a block in cell proliferation and massive cell death were observed. This NVP-AEW541 action in anchorage-independence was accompanied by the inhibition of GSK-3b constitutive phosphorylation, which was observed only when BsB8 cells were deprived of attachment.
GSK3b, which was originally identified for its role in the regulation of glycogen metabolism (Embi et al., 1980) , is also involved in a variety of cellular responses including cytoskeleton regulation (Hanger et al., 1992) , cell cycle progression (Cui et al., 1998; Diehl et al., 1998) , apoptosis (Beurel et al., 2004; Linseman et al., 2004) and cell adhesion (Cordes and van Beuningen, 2003) . It has been also postulated that constitutive phosphorylation of GSK3b found in many tumor cells, including medulloblastoma, improves cell survival and contributes to malignant transformation (DesboisMouthon et al., 2002; Beurel et al., 2004) .
High sensitivity of medulloblastoma cells to NVP-AEW541 observed in anchorage-independent cultures indicates that low doses of this inhibitor used in combination with agents activating GSK3b (dephosphorylation) could be highly effective against detrimental spread of medulloblastoma cells via cerebrospinal fluid in which invasive cells are exposed, at least temporarily, to an anchorage-independent environment.
Results
Growth and survival of BsB8 cells in the presence of the IGF-IR inhibitor, NVP-AEW541 To evaluate potential growth-inhibitory effects of NVP-AEW541 in medulloblastomas, we have selected an aggressive mouse cell line, BsB8, which is JCV T-antigen positive, forms large tumors, and spreads through the CNS following intracranial cell delivery (Wang et al., 2001 Reiss, 2002) . As shown in Figure 1a (control) , and in cultures exposed to 1 and 3 mM NVP-AEW541. Following Propidium Iodide DNA staining, samples were analysed by FACSCalibur (Becton-Dickinson, Franklin Lakes, NJ, USA) using the CellQuest Program (Trojanek et al., 2003) . Data represent an average percentage of BsB8 cells in sub-G1 (apoptotic), G1, S and G2/M phases of the cell cycle (n ¼ 3). An example of flow-cytometric measurement is shown in the lower panel.
IGF-IR-GSK3b signaling interaction in medulloblastoma K Urbanska et al exponential growth of BsB8 cells in monolayer cultures supplemented with 10% FBS was efficiently blocked by 0.5 mM NVP-AEW541. At this relatively low concentration apoptotic death contributed only minimally to the final cell count (data not shown). At 1 mM concentration, however, inhibition of cell proliferation and moderate apoptosis both contributed to the final cell count. In the presence of 1 mM NVP-AEW541, 76% of BsB8 cells were arrested in G1 phase of the cell cycle, and 14.7% of cells underwent apoptosis (sub-G1 cell population) (Figure 1b) . At a higher concentration, NVP-AEW541 treatment triggered massive apoptosis, which reached almost 50% of the sub-G1 cells at 48 h after the treatment, and resulted in a complete elimination of the cells at 72 h time point.
Importantly, results in Figure Enhanced cellular sensitivity to NVP-AEW541 in anchorage-independence It has been shown that IGF-IR protects cells from apoptosis triggered by the condition in which cellular interactions with extracellular matrix proteins are restricted (Valentinis et al., 1998 (Valentinis et al., , 1999 . Although BsB8 mouse medulloblastoma cells grow as typical monolayer cultures, medulloblastomas in general have an intrinsic tendency to flake into subarachnoid spaces and enter other parts of the CNS via cerebrospinal fluid. Therefore, we decided to investigate the effect of IGF-IR inhibition on BsB8 cells, which are forced to grow unattached in suspension cultures. Results in Figure 4 demonstrate that BsB8 cells devoid of attachment (plated on PolyHema-coated dishes (Valentinis et al., 1998 (Valentinis et al., , 1999 ), were much more sensitive to NVP-AEW541 treatment then BsB8 cells growing as monolayer cultures attached to a substratum (compare Figures 1a and 4) . For instance, cell loss in suspension reached almost 50% following 72 h administration of 0.5 mM NVP-AEW541. At the same concentration, cell proliferation in monolayer cultures still exceeded cell loss, since 127 and 63% increases in cell number were observed at 48 and 72 h, respectively (Figure 1a) . Treatment with 1 mM, NVP-AEW541 caused massive cell loss in suspension, however, the same treatment applied to monolayer cultures was at least threefold less effective (compare Figures 1a and 4) .
Inhibition of GSK-3b phosphorylation by NVP-AEW541 in anchorage-independence Next, we investigated the effects of NVP-AEW541 treatment on cell signaling events in BsB8 cells grown either in monolayer or suspension culture conditions. As shown in Figure 5 , BsB8 cells incubated in SFM for 48 h 7 cells/100 ml. After 1 week, 20 ml of DMSO or 1.0 mM NVPAEW541 diluted in DMSO were injected into primary sites of cell injection. The treatment was repeated twice a week for a period of 7 weeks. Data represent an average of tumor weight (n ¼ 5) with s.d.
IGF-IR-GSK3b signaling interaction in medulloblastoma
K Urbanska et al were characterized by very low levels of phosphorylated forms of IGF-IR, IRS-1, Akt and Erk1/2 in both monolayer and suspension cultures. As expected, IGF-I stimulation resulted in a dramatic increase of IGF-IR, IRS-1, Akt and Erk1/2 phosphorylation. When IGF-I stimulation was accompanied by the cell preincubation (20 min) with increasing concentrations of NVP-AEW541, the phosphorylation was partially attenuated by 0.1 mM NVP-AEW541, and was strongly inhibited by 1 and 3 mM NVP-AEW541. We did not observe any major differences in IGF-IR, IRS-1, Erk1/2 and Akt phosphorylation when monolayer and suspension cultures of BsB8 cells were compared. In contrast, the phosphorylation pattern of GSK3b changed dramatically ( Figure 5 , lower panel). Serum starvation of BsB8 cells in monolayer did not reduce the level of GSK-3b serine phosphorylation, which remained unaffected either following IGF-I stimulation or NVP-AEW541 treatment. In suspension cultures, however, GSK3b phosphorylation became highly responsive. In SFM, IGF-IR-GSK3b signaling interaction in medulloblastoma K Urbanska et al GSK-3b phosphorylation declined significantly; increased several fold after IGF-I stimulation; and was low again in cells in which IGF-I stimulation was applied in the presence of NVP-AEW541.
In the next series of experiments, we investigated whether the activation of GSK-3b (decrease in constitutive phosphorylation) observed in anchorageindependence is associated with hypersensitivity of medulloblastoma cells to the NVP-AEW541 treatment. We have used a potent GSK3b inhibitor, lithium chloride (LiCl), which reconstituted phosphorylation of GSK3b in BsB8 cells cultured in suspension, followed by treatment with increasing concentrations of NVP-AEW541 (Figure 6a ). In the presence of LiCl, suspension cultures of BsB8 cells were partially rescued from the toxic effects of NVP-AEW541 treatment showing a significant reduction in cell death at both 48 and 72 h time points (Figure 6b) .
We also attempted to sensitize monolayer cultures of BsB8 cells to NVP-AEW541 by utilizing a well-known donor of nitric oxide, sodium nitroprusside (SNP). The SNP treatment has recently been found to cause the dephosphorylation of the serine 9 residue of GSK3b (Zhang et al., 2005) . Indeed, results in Figure 6c indicate that the presence of SNP efficiently decreased GSK3b phosphorylation at this site. This inhibitory effect of SNP was observed at a concentration of 1 mM, and caused further downregulation of GSK3b phosphorylation at concentrations of 2 and 4 mM. We then used 1 mM SNP and 1 mM NVP-AEW541 to challenge the survival of otherwise quite resistant monolayer cultures of BsB8 cells. In the presence of 1 mM NVP-AEW541 cell cycle arrest and a small decrease in cell number were observed. At the same time points a single dose of SNP (1 mM) also caused cell cycle arrest (data not shown) and an apparent reduction in cell number (Figure 6d ). Simultaneous treatment with 1 mM NVP-AEW541 and 1 mM SNP resulted in 72 and 92% cell loss at 48 and 72 h, respectively (Figure 6d) .
We have also found a synergistic effect of IGF-IR inhibition and GSK3b activation in human medulloblastoma cells, D384, which survive relatively well after treatment with 1 mM NVP-AEW541 (Figure 7c ). In contrast with suspension cultures of BsB8 cells, suspension cultures of D384 cells were quite resistant to NVP-AEW541-mediated dephosphorylation of GSK3b (compare Figure 5 lower right panel and Figure 7a ). As shown in Figure 7b , however, the treatment with SNP caused the dephosphorylation of GSK3b in D384 cells, and the combination of 1 mM NVP-AEW541 and 1 mM SNP resulted in 82% loss of anti-pY1316 IGF-IRb rabbit polyclonal (K2895, kindly provided by Roche); anti-pY612 IRS-1 rabbit polyclonal (BioSource, Camarillo, CA, USA); anti-pS473 Akt, anti-pT202/Y204 ERK1/ 2, and anti-pS21/9 GSK3a/b, were all from Cell Signaling Technology Inc., Beverly, MA, USA. To monitor loading conditions, antibodies against total forms of IGF-IRb, IRS-1, Akt and Erk1/2, GSK3-b, as well as Grb-2, which shows stable protein level in different culture conditions and in different tissues (Wang et al., 2001; Del Valle et al., 2002a; Trojanek et al., 2003) , were utilized. 
K Urbanska et al D384 cells at 48 h after the treatment (Figure 7c ). We have repeated this experiment with another human medulloblastoma cell line, Daoy, which grow as a typical monolayer culture, however, are also able to propagate in suspension. Results presented in Figure 7d clearly indicate that simultaneous treatment of Daoy cells with SNP and NVP AEW541 almost completely eliminated these human medulloblastoma cells from the suspension culture (94.6% cell loss after 48 h); and as already shown for BsB8 cells, the treatment of Daoy cells in monolayer was less effective since almost 18.5% 74.5 (n ¼ 3) of these cells survived the presence of NVP-AEW541 in monolayer.
Discussion
Our results demonstrate that high sensitivity of medulloblastoma cells to the impairment of IGF-IR function by NVPAEW541 was associated with the loss of GSK3b constitutive phosphorylation when cells were devoid of attachment. We have also found that the NVP-AEW541 treatment of monolayer cultures failed to affect GSK3b phosphorylation, and the treatment resulted in G1 arrest with very little apoptosis. Importantly, medulloblastoma cells in monolayer cultures were sensitized to the NVP-AEW541 treatment by SNP-mediated GSK3b dephosphorylation, and cells in suspension cultures were partially rescued from NVP-AEW541-mediated cytotoxicity by LiCl, which restored GSK3b constitutive phosphorylation. GSK3b undergoes a rapid and transient inhibition through site-specific phosphorylation of the serine 9 residue in response to diverse stimuli including NGF, insulin and IGF-I (Cui et al., 1998; Desbois-Mouthon et al., 2001; Arevalo and Chao, 2005) . In this context, activated tyrosine kinase receptors initiate PI3K -Akt signaling cascade, which has been shown to phosphorylate and repress GSK3b proapoptotic activity. In a similar manner, extracellular matrix (ECM)-activated integrins contribute to the inactivation of GSK3b and enhanced cell survival. This interaction involves cell attachment-induced recruitment of integrin-linked kinase (ILK) to the integrin complex, ILK-mediated phosphorylation of Akt, and Akt-mediated phosphorylation of GSK3b (Yau et al., 2005) . It has been also proposed that ILK can phosphorylate GSK3b directly without the contribution of Akt, which could additionally enhance GSK3b inactivation and cell survival following interaction with ECM (Cordes and van Beuningen, 2003; Kumar et al., 2004) .
Another abnormally active pathway in medulloblastoma, which is also associated with GSK3b activity, is shh. In normal circumstances, shh binds its 12-transmembrane receptor, Pathed1 (Pct1; often mutated in medulloblastomas), and releases Pct1-mediated repression of 7-transmembrane protein, smoothened (Smo) leading to the activation of Gil family of transcription factors (Ingham and McMahon, 2001) , as well as N-Myc stabilization (Kenney et al., 2003 (Kenney et al., , 2004 . These IGF-IR-GSK3b signaling interaction in medulloblastoma K Urbanska et al events are thought to be necessary for normal proliferation of cerebellar neuronal precursors. In contrast, N-Myc degradation, which is primed by GSK3b-mediated phosphorylation, is required by cerebellar neuronal precursors to exit the cell cycle during development (Sjostrom et al., 2005; Knoepfler and Kenney, 2006) . In this respect, our attempt to dephosphorylate GSK-3b by SNP could have an additional site effect against medulloblastoma, which includes GSK3b-mediated phosphorylation and subsequent degradation of N-Myc, and associated withdrawal of medulloblastomas from the cell cycle. Normal cells are 'equipped' with different molecular mechanisms, which enable them to inactivate GSK3b to support cell survival. There are also several effective ways to inactivate GSK3b pharmacologically. These include LiCl (Jope, 2003) , clozapine (Kang et al., 2004) and valproate (Kim et al., 2005) . In contrast, it is much more difficult to dephosphorylate and activate GSK3b. Our results demonstrate that the inhibition of IGF-IR in BsB8 cells devoid of attachment significantly downregulated GSK3b phosphorylation and accordingly compromised cell survival. In contrast, the inhibition of IGF-IR or cell culture in suspension, were inefficient in challenging GSK3b phosphorylation when applied separately. We have tested several factors, which have a potential of dephosphorylating GSK3b. For instance, we have tested without much success the PI3-kinase inhibitor, LY294002 and N-methyl D-aspartate (NMDA) receptor activator, NMDA, which has previously been reported to dephosphorylate GSK3b in forebrain neurons (Szatmari et al., 2005) . Instead, we have obtained positive responses by utilizing simultaneous treatment of BsB8 cells with SNP and NVP-AEW541. This resulted in a significant GSK3b dephosphorylation and massive loss of BsB8 cells in monolayer cultures. Of interest, SNP which is clinically approved antihypertensive agent (Cheng et al., 2005) , and serves as a donor of nitric oxide, has been also found as a potent GSK3b activator (Zhang et al., 2005) . In this respect, recent reports have shown a strong SNP-mediated cytotoxicity against different tumor cell lines in vitro (Blackburn et al., 1998; Chao et al., 2004) , and our study also has demonstrated its effectiveness, in combination with IGF-IR inhibition, against otherwise resistant human medulloblastoma cell line, D384 (Figure 7 ).
In conclusion, the IGF-IR inhibitor (NVP-AEW541) in combination with the GSK3b activator, SNP, could be highly effective against primary medulloblastoma tumors, as well as metastatic dissemination of medulloblastomas via cerebrospinal pathways in which these tumor cells are exposed, at least temporarily, to the environment in which cellular interactions with extracellular matrix are restricted. IGF-IR-GSK3b signaling interaction in medulloblastoma K Urbanska et al
Materials and methods

Cell culture
The following cell lines were used in this study: mouse medulloblastoma, BsB8, isolated from cerebellar tumor of transgenic mouse expressing an early genome of human polyomavirus JC (Krynska et al., 1999; Wang et al., 2001) ; and two human medulloblastoma cell lines, D384 Med and Daoy. D384 are metastatic medulloblastomas isolated from peritoneal ascietes from a boy with medulloblastoma (ATCC# HTB-185), and Daoy derive from a tumor in the posterior fossa of a 4 years old boy (ATCC# HTB186). In addition, BsB8 is a very aggressive cell line, which forms large tumors in subcutaneous tissue, as well as intracranial tumors following stereotactic injection of a small number of cells in to the brain, which have the ability of spreading into cerebellum (Reiss, 2002; Wang et al., 2004) .
Cell growth and survival in suspension
Detailed description is provided in Supplementary Materials.
Cell cycle analysis
Aliquots of cells, 1 Â 10 6 /ml, were fixed in 70% ethanol for 30 min at 41C. Cells were centrifuged at 1600 r.p.m. and the resulting pellets were resuspended in 1 ml of freshly prepared Propidium Iodide/RNaseA solution. Cell cycle distribution was analysed by FACSCalibur (Becton-Dickinson, Franklin Lakes, NJ, USA) using the CellQuest Program (Trojanek et al., 2003) .
Clonogenic assay
Cells were plated at 5 Â 10 2 on 12-well culture plates (Costar, Corning, NY, USA) in DMEM supplemented with 10% FBS. Following attachment, cells were treated with 1 mM NVP-AEW541. Colonogenic potential was evaluated day 10 after treatment by staining the cells with 0.25% Brilliant Blue in methanol, and macroscopic counting of clones.
Western blot, Immunoprecipitation and Immunocytofluorescence Detailed descriptions are provided in Supplementary materials.
Subcutaneous tumor growth NIH Swiss nude mice were injected s.c. with 1 Â 10 7 BsB8 cells (100 ml) in lower neck area as previously described . After 1 week, 20 ml of 10 mM NVP AEW 541 in DMSO was delivered via intratumoral injection. Animals injected with DMSO only were used as control. Intratumoral drug delivery was repeated twice a week for total period of 7 weeks, animals were killed, and tumor tissue excised for analysis.
